Human immune systems have a 'fountain of youth' and scientists are trying to activate it

Aging bodies usually slow down. Immune defenses are no exception, as infections hit harder and vaccines work less well. Yet a subset of older adults carry unusually youthful immune features, and that wrinkle changes the story in surprising ways.

A new perspective argues that keeping parts of the immune system young late in life can come with a cost. The tradeoff shows up most clearly in a blood vessel disease that strikes older adults and can threaten sight and the heart.

Youthful immune traits in elders

The perspective is led by Cornelia M. Weyand, M.D., Ph.D., and Jörg J. Goronzy, M.D., Ph.D., at Mayo Clinic. Their work explores how retained youthful traits in T cells line up with disease patterns seen in late life.

“We propose that sustained immune youthfulness can be detrimental to the aging host, while immune aging may be a beneficial adaptation,” wrote Weyand and Goronzy.

The core message is not a rebuke of aging, but a call to understand which immune features help and which harm as years add up.

The authors focus on a form of autoimmunity in which the body’s defenses misidentify self as threat.

They point to patterns showing that some older patients retain a T cell pool that behaves more like that of much younger people, with strong renewal and rapid responses.

Those traits sound helpful during an infection. In the wrong context, they can feed persistent inflammation in tissues that never needed defending in the first place.

Giant cell arteritis is a late life risk

Giant cell arteritis is an autoimmune vasculitis that targets medium and large arteries and can narrow vessels, reduce blood flow, and damage the vessel wall. It is the most common vasculitis in older adults, especially among people of Northern European ancestry.

Across populations, the pooled incidence is about 10 cases per 100,000 people older than 50, with higher rates in some regions and lower in others.

That number helps explain why clinicians are trained to keep an eye out for new headaches, jaw pain, and sudden visual changes in older patients.

Prevalence climbs with age, peaking in the 70s and 80s, and it affects women more often than men. Those facts line up with the perspective’s central point about late-life immune patterns.

Untreated or smoldering disease can lead to permanent vision loss or aortic complications, including aneurysm, which underscores why accurate diagnosis and monitoring matter. Fast steroid treatment saves sight, but long-term disease control remains a challenge.

Persistent vessel inflammation

A line of studies has mapped a small set of T cells with self-renewing traits in inflamed arteries of older patients.

These cells look and act younger than expected for age, and they appear to supply the fuel for chronic inflammation.

The cells in question are stem-like memory CD4+ T cells. They carry a transcription factor profile consistent with renewal capacity and sit near the lesions that clinicians see on imaging or biopsy.

Within the vessel wall, they cluster in tertiary lymphoid structures, small immune neighborhoods that help them persist. Their presence explains how inflammation can recur even when symptoms seem quiet.

Failed checkpoints in immune aging

The immune system relies on immune checkpoints to keep T cells from overreacting, especially in tissues that need peace. Those checkpoints include receptor-ligand pairs that send inhibitory signals and help maintain tolerance to self.

Several lines of work show that the axis of PD-1 and PD-L1 is off balance in this disease, with low PD-L1 on vascular dendritic cells and macrophages that should be braking T cells. 

That imbalance removes a layer of control and helps explain why inflammation is hard to shut down in affected arteries.

Other checkpoint pathways may falter as well. A 2023 study reported a defective immune checkpoint impaired, in giant cell arteritis leading to a pathogenic immune response.

This checkpoint normally regulates T cell activation and prevents excessive inflammation. This research points to a broader failure to impose restraint on activated T cells.

Clinical experience also shows that turning off checkpoints in cancer can, in rare cases, trigger vasculitis.

Case reports and reviews link checkpoint inhibitor treatment to giant cell arteritis in older patients, which fits the idea that removing brakes can unmask self-reactivity.

Why some aging may help

Aging changes the adaptive immune system in predictable ways. Vaccine responses dip, naive T cells become rarer, and recall responses dominate, a set of shifts often grouped under immunosenescence.

Those changes are not uniformly bad. Reviews of T cell aging highlight adaptations in self-renewal, quiescence, and cellular senescence that appear to limit runaway activation in older adults, which may protect against autoimmunity in some contexts.

The perspective adds a useful twist by suggesting that delayed immune aging can be maladaptive in late life. In other words, a youthful T cell program, sustained for decades, may become a liability when new tissue changes accumulate.

Age adds new neoantigens, altered self molecules that T cells can misread as foreign. A renewing T cell pool plus a higher antigenic load makes a potent mix, especially in tissues exposed to wear and tear.

Clinical impact of immune aging

A practical question follows: how do we identify older adults whose immune systems remain unusually youthful, and who might be at higher risk for late-life autoimmunity.

The answer will likely combine immune profiling with imaging and careful clinical phenotyping.

Mayo Clinic has framed a strategy around prediction and early interception, a push that leaders describe under the Precure initiative, which aims to predict and prevent disease before it becomes serious. 

For vascular inflammation, that could mean spotting the signatures of self-renewing T cells, then tailoring treatment to shut off the supply rather than only chasing the flames.

The study is published in Nature Aging.

—–

Like what you read? Subscribe to our newsletter for engaging articles, exclusive content, and the latest updates. 

Check us out on EarthSnap, a free app brought to you by Eric Ralls and Earth.com.

—–